• New distribution agreement with Swedish Trading Company (STC)
• Covers Hong Kong, Macau, and Greater China Bay Area
• Initial 3-year exclusive term with renewal options

ReNerve Limited, an Australian biotech company specializing in peripheral nerve injury repair, has announced a new distribution agreement with Swedish Trading Company (STC), a leading medical device distributor based in Hong Kong. The agreement covers the Hong Kong, Macau, and Greater Bay Area markets, representing a combined population of approximately 88 million. STC will handle importation, warehousing, marketing, sales, and distribution of ReNerve's products in these regions. The agreement is exclusive for an initial term of three years, with performance milestones and renewal options. This partnership follows ReNerve's recent expanded product approval across these jurisdictions and aims to leverage STC's established network of hospitals and surgeons to drive market penetration.